The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
On-Demand Educational Webinars
The perioperative services administration at Massachusetts General created a rigorous and rapid approach to raising the level of cost awareness among…
On-Demand Educational Webinars
Outsourcing of hospital functions is a common and growing practice in the U.S. and comprises on average 25% of total non-labor spend in hospitals.…
Webcast
Lana Makhanik and Peter Fiorentino discuss discus why Beth Israel Deaconess Medical Center is breathing easier after they overhauled their inventor
Podcasts
Hear one provider’s ongoing process of UDI implementation, from deciphering acronyms and educating interdepartmental staff, to working with vendors
On-Demand Educational Webinars
In this webinar, we discuss the clinical contract evaluation process, including government requirements, expectations, and improving contract…
Podcasts
A thought-leader panel discussion about the role of GPOs within the changing healthcare landscape and the and the daily decision of using a GPO or